MFN2 and Alzheimer disease: Resveratrol has been shown to improve mitochondrial fitness and to decrease Aβ levels in the CSF of AD patients [246], to increase the levels of Mfn2 [247], to induce Ca2+ shuttling from the ER to mitochondria and to enhance the MERCS in cancer cells [248].